Center for Neurodegeneration and Experimental Therapeutics (CNET)

CNET_groupEstablished February 2, 2007, CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to clinical care of patients.

These neurodegenerative disorders include Alzheimer’s disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS, known as Lou Gehrig’s disease), and other less common neurodegenerative disorders that occur more frequently with advancing age. A common feature of these diseases is that in each there is selective premature death and malfunction of neurons in specific parts of the brain, which gives rise to the characteristic symptoms. At present there are treatments which can provide some temporary improvement of the symptoms of these diseases, but there are no treatments which can substantially slow the underlying brain degeneration.

Research

Recent discoveries have provided important clues to the causes of neurodegenerative disorders, and have revealed that these diseases, which are distinct in their symptoms, in fact share many common mechanisms. The primary goal of UAB CNET is to accelerate the translational process, and move basic scientific discoveries from the laboratory to clinical use as rapidly and safely as possible, through an integrated, multi-disciplinary approach involving basic scientists, clinical scientists and a variety of supporting disciplines.

Explore our research labs >>

View our CNET faculty >>

Contact Us

For general questions, contact:
CNET
Civitan International Research Center
Suite 516
1719 6th. Avenue South
Birmingham, AL 35294
CNET@uab.edu
205.996.6329

Support CNET